← Every company
Revvity Inc Patents
What Revvity Inc has filed at the patent office — applications as well as grants, because a filing is on the record eighteen months before anyone has to say what it was for.
RVTY on carbonthat →Filings on file
34
Granted
0
Still pending
34
Filed under
8 names
34 filings
Newest filing first. A pending application has no patent number yet, and most never get one.
| Invention | Patent |
|---|---|
| METHODS, COMPOSITIONS, AND KITS FOR INHIBITING FORMATION OF ADAPTER DIMERSC12Q 1/6855, C40B 50/06, C12N 9/222, C12N 15/1093, C12Q 1/6806, C12Q2525/186, C12Q2525/207, C12Q2535/122, C12Q2521/501, C12Q2525/117, C12Q2525/191Filed as Revvity Health Sciences, Inc.2026-04-16Kevin D. Allen | pending |
| MICROFLUIDIC CHIP AND ELECTRICAL INTERFACE FOR MICROCHIP ELECTROPHORESISB01L 3/502715, G01N 27/44713, G01N 27/44791, B01L2200/16, B01L2300/0819, B01L2300/0829, B01L2400/0421Filed as Revvity Health Sciences, Inc.2025-12-09Allen Curtis Dennison | pending |
| PIPETTING APPARATUS AND METHODSB01L 3/0217, B01L 3/0237, G01F 11/02, B01L 3/022, B01L 3/0224, B01L 3/0227, B01L 3/0231, B01L 3/0234, B01L 3/0279, B01L2200/0615, B01L2200/146, B01L2200/148, B01L2400/0487, G01F 11/021, G01F 11/029, G01N 35/1016, G01N2035/103Filed as Revvity Health Sciences, Inc.2025-11-05Thomas Perroud | pending |
| REFERENCE STANDARDS FOR PLASMID DNA CONFORMATION ASSESSMENT AND SIZING ANALYSISC12Q 1/6806, C12Q 1/6876, G01N 33/582, C12Q2563/107, C12Q2563/173, C12Q2565/133, C12Q2565/629, C12Q2545/113, C12Q2527/125, C12Q2527/137, C12Q2565/125Filed as Revvity Health Sciences, Inc.2025-10-28Dipti Rasiklal Mehta | pending |
| REFERENCE STANDARDS FOR PLASMID DNA CONFORMATION ASSESSMENT AND SIZING ANALYSISFiled as REVVITY HEALTH SCIENCES, INC.2025-10-28DIPTI RASIKLAL MEHTA | pending |
| METHODS, SYSTEMS, AND COMPUTER READABLE MEDIA FOR FLUORESCENCE TOMOGRAPHY IMAGE ACQUISITION AND RECONSTRUCTION USING LINE SOURCESFiled as REVVITY HEALTH SCIENCES, INC.2025-08-22MICHAEL JOSEPH MASSEY | pending |
| METHODS, SYSTEMS, AND COMPUTER READABLE MEDIA FOR FLUORESCENCE TOMOGRAPHY IMAGE ACQUISITION AND RECONSTRUCTION USING LINE SOURCESA61B 5/0073, G01N 21/6456, A61B 5/0071, G01N 21/4795, G01N 21/6454, G01N2021/1706, G01N2021/1787, G01N2021/6419, G01N2021/6421, G01N2201/0625, G01N2201/0626, G01N2201/0635, G01N2201/0636, G01N2201/105Filed as Revvity Health Sciences, Inc.2025-08-22Michael Joseph Massey | pending |
| MICROFLUIDIC ELECTROPHORESIS-MEDIATED CHARACTERIZATION OF PLASMID DNA ISOFORMSFiled as REVVITY HEALTH SCIENCES, INC.2025-06-27DIPTI RASIKLAL MEHTA | pending |
| MICROFLUIDIC ELECTROPHORESIS-MEDIATED CHARACTERIZATION OF PLASMID DNA ISOFORMSC12Q 1/6816, G01N 27/44726, C12Q 1/6806, G01N 21/6486, G01N 27/44791, C12Q2565/137, C12Q2565/125, C12Q2565/629, C12Q2563/173, C12Q2563/107Filed as Revvity Health Sciences, Inc.2025-06-27Dipti Rasiklal MEHTA | pending |
| COMPOUNDS AND METHODS RELATING TO TESTING FOR LYSOSOMAL STORAGE DISORDERSC12Q 1/34, C07C 233/18, C07H 15/10, G01N2333/924Filed as Revvity Health Sciences, Inc.2025-04-09Alexander Cherkassky | pending |
| MEANS FOR GENERATING ADENOVIRAL VECTORS FOR CLONING LARGE NUCLEIC ACIDSC12N 15/63, C12N 7/00, C12N 15/86, C12N2710/10343, C12N2710/10351, C12N2800/204, C12N2800/30, C12N2800/50, C12N2820/002, C12N2820/60, C12N2830/55Filed as REVVITY GENE DELIVERY GMBH2025-01-17Christian Thirion | pending |
| PRODUCTION OF VIRAL VECTORSC12N 15/86, C12N 7/00, C12N 15/113, C12N2310/113, C12N2310/141, C12N2310/531, C12N2740/10051, C12N2740/16043, C12N2740/16051, C12N2750/14143, C12N2750/14151, C12N2830/48, C12N2310/14Filed as Revvity Gene Delivery GmbH2025-01-17Michael Otto SALOMON | pending |
| Three-Dimensional Luminescence ImagingG06T 7/0012, G06T 7/62, G06T 7/11, G06T 7/70, G01N 21/763, A61B 5/0037, A61B 5/0071, A61B 5/0073, A61B 5/0075Filed as Revvity Health Sciences, Inc.2025-01-16Joshua Kempner | pending |
| PURIFICATION OF NUCLEIC ACIDS IN A MICROFLUDIC CHIP BY SEPARATIONB01L 3/502753, B01L 3/502761, B01L 3/021, B01L 3/50273, B01L 3/5085, B01L 9/527, B01L2200/027, B01L2200/0652, B01L2200/0663, B01L2200/0668, B01L2300/0816, B01L2300/087, B01L2300/1827, B01L2400/0415, B01L2400/043, B03C 1/01, B03C 1/023, B03C 1/0332, B03C 1/288, B03C2201/18, C12N 15/1013, G01N 35/0098Filed as Revvity Health Sciences, Inc.2025-01-15Michael NILSSON | pending |
| PURIFICATION OF NUCLEIC ACIDS IN A MICROFLUDIC CHIP BY SEPARATIONB01L 3/502753, B01L 3/502761, B01L 3/021, B01L 3/50273, B01L 3/5085, B01L 9/527, B01L2200/027, B01L2200/0652, B01L2200/0663, B01L2200/0668, B01L2300/0816, B01L2300/087, B01L2300/1827, B01L2400/0415, B01L2400/043, B03C 1/01, B03C 1/023, B03C 1/0332, B03C 1/288, B03C2201/18, C12N 15/1013, G01N 35/0098Filed as Revvity Health Sciences, Inc.2025-01-15Michael NILSSON | pending |
| PURIFICATION OF NUCLEIC ACIDS IN A MICROFLUDIC CHIP BY SEPARATIONB01L 3/502753, B01L 3/502761, B01L 3/021, B01L 3/50273, B01L 3/5085, B01L 9/527, B01L2200/027, B01L2200/0652, B01L2200/0663, B01L2200/0668, B01L2300/0816, B01L2300/087, B01L2300/1827, B01L2400/0415, B01L2400/043, B03C 1/01, B03C 1/023, B03C 1/0332, B03C 1/288, B03C2201/18, C12N 15/1013, G01N 35/0098Filed as Revvity Health Sciences, Inc.2025-01-15Michael NILSSON | pending |
| PURIFICATION OF NUCLEIC ACIDS IN A MICROFLUDIC CHIP BY SEPARATIONB01L 3/502753, B01L 3/502761, B01L 3/021, B01L 3/50273, B01L 3/5085, B01L 9/527, B01L2200/027, B01L2200/0652, B01L2200/0663, B01L2200/0668, B01L2300/0816, B01L2300/087, B01L2300/1827, B01L2400/0415, B01L2400/043, B03C 1/01, B03C 1/023, B03C 1/0332, B03C 1/288, B03C2201/18, C12N 15/1013, G01N 35/0098Filed as Revvity Health Sciences, Inc.2025-01-15Michael NILSSON | pending |
| PURIFICATION OF NUCLEIC ACIDS IN A MICROFLUDIC CHIP BY SEPARATIONB01L 3/502753, B01L 3/502761, B01L 3/021, B01L 3/50273, B01L 3/5085, B01L 9/527, B01L2200/027, B01L2200/0652, B01L2200/0663, B01L2200/0668, B01L2300/0816, B01L2300/087, B01L2300/1827, B01L2400/0415, B01L2400/043, B03C 1/01, B03C 1/023, B03C 1/0332, B03C 1/288, B03C2201/18, C12N 15/1013, G01N 35/0098Filed as Revvity Health Sciences, Inc.2025-01-15Michael NILSSON | pending |
| PURIFICATION OF NUCLEIC ACIDS IN A MICROFLUDIC CHIP BY SEPARATIONB01L 3/502753, B01L 3/502761, B01L 3/021, B01L 3/50273, B01L 3/5085, B01L 9/527, B01L2200/027, B01L2200/0652, B01L2200/0663, B01L2200/0668, B01L2300/0816, B01L2300/087, B01L2300/1827, B01L2400/0415, B01L2400/043, B03C 1/01, B03C 1/023, B03C 1/0332, B03C 1/288, B03C2201/18, C12N 15/1013, G01N 35/0098Filed as Revvity Health Sciences, Inc.2025-01-15Michael NILSSON | pending |
| BARCODING OF NUCLEIC ACIDSC12N 15/1006, C12Q 1/6806, C12Q 1/6869, C12Q 1/6848, C12Q2525/15, C12Q2525/191, C12Q2535/122, C12Q2537/143, C12Q2565/543, C12Q2563/179, C12Q2531/113Filed as Revvity Holdings, Inc.2025-01-03Dr. Melinda Jasper | pending |
| Systems and Methods for Facilitating Placement of Labware ComponentsH04N 9/3102, B01L 3/5085, B01L2200/025, B01L2200/143, B01L2300/0829, G01B 11/26, G02B 21/06, G02B 21/26, G03B 21/005, G03B 21/26, H04N 9/315, H04N 9/3194Filed as Revvity Health Sciences, Inc.2025-01-02Stephen Allen | pending |
| GAMMA SOURCE DEVICES AND RELATED SYSTEMS AND METHODSG01T 7/00, G01T 7/005Filed as Revvity Health Sciences, Inc.2024-12-12Michael Belobraydich | pending |
| SYSTEMS AND METHODS FOR TESTING FOR INFECTIOUS DISEASEFiled as REVVITY HEALTH SCIENCES, INC.2024-12-11MOREY RICHARD KRAUS | pending |
| SYSTEMS AND METHODS FOR TESTING FOR INFECTIOUS DISEASEB01L 3/502, B01L 3/563, B01L 3/523, B01L 3/527, B01L 3/5635, B01L 7/52, B01L2200/16, B01L2300/044, B01L2300/0654, B01L2300/0672, B01L2400/049, G01N2021/6419, G01N2021/6421, G01N2021/6482Filed as Revvity Cellular Technologies GmbH2024-12-11Morey Richard Kraus | pending |
| REFERENCE STANDARDS FOR PLASMID DNA CONFORMATION ASSESSMENT AND SIZING ANALYSISFiled as Revvity, Inc.2024-10-28Dr. Dipti Rasiklal Mehta | pending |
| LAB TOOLS AND LABORATORY LIQUID HANDLING SYSTEMS AND METHODS INCLUDING SAMEFiled as REVVITY HEALTH SCIENCES, INC.2024-10-08VLADIMIR KRASHENININ | pending |
| METHODS, SYSTEMS, AND COMPUTER READABLE MEDIA FOR FLUORESCENCE TOMOGRAPHY IMAGE ACQUISITION AND RECONSTRUCTION USING LINE SOURCESFiled as Revvity Health Sciences, Inc.2024-08-22Michael Joseph Massey | pending |
| POLYNUCLEOTIDES WITH SELECTION MARKERSC12N 15/86, C07K 16/32, C07K2317/24, C12N 9/93, C12N2740/15043, C12N2800/90, C12Y 603/01002, C12N 15/90, C12N 15/85, C12N 15/907, C12N2710/16122, C12N2740/16043, C12N2800/107, C12N2800/40, C12N2830/20, C12N2830/205, C12N2830/60Filed as Revvity Discovery Limited2024-08-08Delphine Cougot | pending |
| MICROFLUIDIC ELECTROPHORESIS-MEDIATED CHARACTERIZATION OF PLASMID DNA ISOFORMSFiled as Revvity Health Sciences, Inc.2024-06-28Dr. Dipti Rasiklal MEHTA | pending |
| METHODS FOR DETECTING MUTATIONS IN TARGET NUCLEIC ACIDS USING DUAL PROBESFiled as REVVITY HEALTH SCIENCES, INC.2024-06-07ZHIXIANG LU | pending |
| LABWARE ALIGNING SYSTEMS AND LIQUID HANDLING SYSTEMS AND METHODS INCLUDING SAMEB01L 9/54, G01N 35/0099, B01L 3/5085, B01L2200/025, B01L2300/0829, G01N 35/1011, G01N2035/103Filed as Revvity Cellular Technologies GmbH2024-05-22Nils Nissen | pending |
| Systems and Methods for 3D Reconstruction of Anatomical Organs and Inclusions Using Short-Wave InfraG06T 12/20, A61B 5/0075, G06T2211/456, G06T 12/10, A61B 5/0035, A61B 5/0062, A61B 5/0071, A61B 5/0073, A61B 5/704, A61B2503/40, A61B2560/0223, G01B 11/24, G01N 21/35, G01N2021/1787Filed as Revvity Health Sciences, Inc.2024-04-22Ali Behrooz | pending |
| GAMMA SOURCE DEVICES AND RELATED SYSTEMS AND METHODSFiled as REVVITY HEALTH SCIENCES, INC.2024-02-29MICHAEL BELOBRAYDICH | pending |
| Method for Producing Genetically Modified CellsA61K 40/15, C12N 9/22, C12N 15/102, C12N2310/20, A61P 35/00, A61K2239/10, A61K2239/48, A61K 40/4211, A61K 40/31, A61K 40/50, A61K 40/11, C12N 9/226, C07K 14/7051, C07K 14/70535, C07K2319/03, C07K2319/85, C12N 5/0636, C12N 5/0646, C12N 5/0696, C12N 9/78, C12N 15/11, C12N 15/113, C12N 15/1138, C12N 15/86, C12N 15/90, C12N2310/315, C12N2510/00, C12N2750/14143, C12N2310/321, C12N2310/3521, C12N2310/3519, C12N2310/16Filed as Revvity Discovery Limited2024-02-06Shengkan Jin | pending |
Filings are matched to the company by applicant name, so a subsidiary filing under its own name is only here if that name resolves to this company. The applicant is printed as filed, which makes a wrong match visible. A patent is not a product: most applications are never granted, and most grants are never built.
More on RVTY
Company overviewEverything on RVTY in one place, with the price.SEC filingsWhat RVTY's 8-Ks say happened: results, departures, auditor changes.Insider tradingWhat RVTY's own officers and directors buy and sell.Planned salesSales RVTY insiders have filed notice of.Who owns itEvery manager reporting a position in RVTY.Funds holding itWhich funds and ETFs hold RVTY, and how big a bet.LobbyingWhat RVTY spends lobbying Congress, and on what.Who lobbies for itThe lobbyists on RVTY's account, and who they worked for.Federal contractsWhat federal agencies pay RVTY.